Total Payments
$5,753
2024 Payments
$1,632
Companies
18
Transactions
367
Medicare Patients
191
Medicare Billing
$23,198
Payment Breakdown by Category
Food & Beverage$5,678 (98.7%)
Education$74.18 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,678 | 365 | 98.7% |
| Education | $74.18 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,136 | 121 | $0 (2024) |
| Lundbeck LLC | $820.34 | 41 | $0 (2024) |
| Alkermes, Inc. | $721.67 | 39 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $694.24 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $424.88 | 19 | $0 (2024) |
| Indivior Inc. | $353.43 | 21 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $303.41 | 20 | $0 (2024) |
| ITI, Inc. | $291.24 | 18 | $0 (2023) |
| Axsome Therapeutics, Inc. | $207.03 | 14 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $184.08 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,632 | 98 | Otsuka America Pharmaceutical, Inc. ($315.77) |
| 2023 | $1,703 | 109 | ABBVIE INC. ($463.41) |
| 2022 | $1,767 | 116 | ABBVIE INC. ($280.99) |
| 2021 | $650.49 | 44 | Lundbeck LLC ($127.24) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $51.84 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.19 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: ADHD | ||||||
| 11/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CNS | ||||||
| 11/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: CNS | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 35 | 106 | $20,140 | $4,129 |
| 2022 | 2 | 41 | 140 | $39,385 | $7,371 |
| 2021 | 2 | 56 | 166 | $50,630 | $6,958 |
| 2020 | 3 | 59 | 119 | $30,835 | $4,740 |
Total Patients
191
Total Services
531
Medicare Billing
$23,198
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 106 | $20,140 | $4,129 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 122 | $35,390 | $6,756 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $3,995 | $614.63 | 15.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 111 | $33,855 | $3,862 | 11.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 55 | $16,775 | $3,096 | 18.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 76 | $23,180 | $2,548 | 11.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 28 | $3,080 | $1,329 | 43.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 15 | $4,575 | $863.38 | 18.9% |
About Cory Rabe, APRN
Cory Rabe, APRN is a Psychiatric/Mental Health healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2013. The National Provider Identifier (NPI) number assigned to this provider is 1619218302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cory Rabe, APRN has received a total of $5,753 in payments from pharmaceutical and medical device companies, with $1,632 received in 2024. These payments were reported across 367 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($5,678).
As a Medicare-enrolled provider, Rabe has provided services to 191 Medicare beneficiaries, totaling 531 services with total Medicare billing of $23,198. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Lincoln, NE
- Active Since 03/06/2013
- Last Updated 05/12/2016
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619218302
Products in Payments
- REXULTI (Drug) $1,250
- VRAYLAR (Drug) $1,136
- ARISTADA (Drug) $579.91
- INVEGA SUSTENNA (Drug) $415.47
- CAPLYTA (Drug) $372.92
- PERSERIS (Drug) $353.43
- INGREZZA (Drug) $303.41
- Auvelity (Drug) $207.03
- NUEDEXTA (Drug) $202.49
- HETLIOZ (Drug) $184.08
- LATUDA (Drug) $144.34
- Vivitrol (Drug) $118.25
- COBENFY (Drug) $97.30
- AUSTEDO (Drug) $68.41
- UZEDY (Drug) $52.00
- TRINTELLIX (Drug) $49.11
- Dyanavel XR (Drug) $48.31
- Nuedexta (Drug) $47.75
- ABILIFY MAINTENA (Drug) $34.37
- ABILIFY ASIMTUFII (Drug) $27.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Lincoln
Ms. Helen Trotter, Aprn, APRN
Psychiatric/Mental Health — Payments: $7,314
Psychiatric/Mental Health $7,314
Nathan Warner, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $7,016
Psychiatric/Mental Health $7,016
Marcia Carlson, Aprn-Np, APRN-NP
Psychiatric/Mental Health — Payments: $6,880
Psychiatric/Mental Health $6,880
Michelle Lemon, Aprn, APRN
Psychiatric/Mental Health — Payments: $6,582
Psychiatric/Mental Health $6,582
Trisha Jobman, Aprn-Np, APRN-NP
Psychiatric/Mental Health — Payments: $6,355
Psychiatric/Mental Health $6,355
Serena Macauley, Msn, Aprn, MSN, APRN
Psychiatric/Mental Health — Payments: $5,362
Psychiatric/Mental Health $5,362